Document is current
Any future updates will be listed below
-
Authors
Alizadeh, Madeline
Wong, Uni
Siaton, Bernadette C.
Patil, Seema A.
George, Lauren
Raufman, Jean-Pierre
Scott, William H.
von Rosenvinge, Erik C.
Ravel, Jacques
Cross, Raymond K.
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK067872-19, T32 DK067872-19)
- License Information
-
More Information
Article History
Received: 11 March 2024
Accepted: 5 May 2024
First Online: 20 June 2024
Declarations
:
: RKC has received income from consulting and participation in advisory boards for Abbvie, Adiso, BMS, Fresenius Kabi, Fzata, Janssen, Magellan Health, Option Care, Pharmacosmos, Pfizer, Sandoz, Samsung Bioepis, Sebela, and Takeda, is a Member of the Executive Committee for the IBD Education Group, and is Scientific Co-Director of the CorEvitas Registry. J.R. is cofounder of LUCA Biologics, and has received income from consulting for Biocodex.
: The LOCATION-IBD study was first approved by the University of Maryland, Baltimore’s Institutional Review Board on March 18th, 2021, under protocol number HP-00094082.
: All participants provided written informed consent.
